MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, IMMX has $104,840,341 in assets. $11,044,171 in debts. $93,928,566 in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1001.31%
Quick Ratio
1001.31%
Cash Ratio
929.02%
Debt to Asset Ratio
10.53%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Short-term investments
    • Right-of-use asset, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities - lo...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
93,928,566
Short-term investments
6,480,860
Prepaid expenses and other current assets
828,329
Total current assets
101,237,755
Other assets
20,418
Deferred offering costs
93,630
Right-of-use asset, net
966,917
Property and equipment, net
2,521,621
Total assets
104,840,341
Accounts payable and accrued expenses
9,971,207
Operating lease liabilities - current
139,339
Total current liabilities
10,110,546
Operating lease liabilities - long term
933,625
Total liabilities
11,044,171
Common stock, 0.0001 par value 200,000,000 shares authorized 53,023,466 shares issued and 52,951,103 shares outstanding at december 31, 2025, and 27,612,383 shares issued and 27,540,020 shares outstanding at december 31, 2024
5,301
Additional paid-in capital
198,293,956
Accumulated other comprehensive income
60,160
Accumulated deficit
-104,463,284
Treasury stock at cost, 72,363 shares as of december 31, 2025, and 2024
99,963
Total stockholders equity
93,796,170
Total liabilities and stockholders equity
104,840,341
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$93,928,566 Short-term investments$6,480,860 Prepaid expenses andother current assets$828,329 Total current assets$101,237,755 Property and equipment,net$2,521,621 Right-of-use asset, net$966,917 Deferred offering costs$93,630 Other assets$20,418 Total assets$104,840,341 Total liabilities andstockholders equity$104,840,341 Total stockholdersequity$93,796,170 Total liabilities$11,044,171 Accumulated deficit-$104,463,284 Treasury stock at cost,72,363 shares as of...$99,963 Additional paid-in capital$198,293,956 Total currentliabilities$10,110,546 Operating leaseliabilities - long term$933,625 Accumulated othercomprehensive income$60,160 Common stock, 0.0001par value...$5,301 Accounts payable andaccrued expenses$9,971,207 Operating leaseliabilities - current$139,339

Immix Biopharma, Inc. (IMMX)

Immix Biopharma, Inc. (IMMX)